Ardent Health (ARDT) Cost of Revenue (2023 - 2026)

Ardent Health (ARDT) has reported Cost of Revenue for 4 consecutive years, with $165.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue rose 26.29% year-over-year to $165.2 million; the TTM figure through Mar 2026 stood at $805.1 million (down 22.74% YoY), while the FY2025 annual figure was $1.1 billion, up 4.82% from the prior year.
• Cost of Revenue came in at $165.2 million for Q1 2026 at Ardent Health, down from $277.5 million in the prior quarter.
• The five-year high for Cost of Revenue was $678.3 million in Q4 2024, with the low at -$292.0 million in Q4 2023.
• Average Cost of Revenue over 4 years is $170.5 million, with a median of $147.2 million recorded in 2025.
• Across the five-year window, Cost of Revenue soared 332.3% in 2024 and tumbled 59.08% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at -$292.0 million in 2023, then soared by 332.3% to $678.3 million in 2024, then plunged by 59.08% to $277.5 million in 2025, then tumbled by 40.49% to $165.2 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $165.2 million, $277.5 million, and $198.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.